The numbers weren’t pretty, but the fourth-quarter loss does not signal a cash crunch or the necessity of bitcoin sales, say analysts.Markets, Strategy, NewsRead More

You might also be interested in reading ROSEN, A LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ZBIO.